Alain J Nordmann
Overview
Explore the profile of Alain J Nordmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
2025
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schandelmaier S, Briel M, Saccilotto R, Olu K, Arpagaus A, Hemkens L, et al.
Cochrane Database Syst Rev
. 2017 Jun;
6:CD009744.
PMID: 28616955
Background: Nicotinic acid (niacin) is known to decrease LDL-cholesterol, and triglycerides, and increase HDL-cholesterol levels. The evidence of benefits with niacin monotherapy or add-on to statin-based therapy is controversial. Objectives:...
2.
Jakob T, Nordmann A, Schandelmaier S, Ferreira-Gonzalez I, Briel M
Cochrane Database Syst Rev
. 2016 Nov;
11:CD009753.
PMID: 27849333
Background: Fibrates are effective for modifying atherogenic dyslipidaemia, and particularly for lowering serum triglycerides. However, evidence that fibrates reduce mortality and morbidity associated with cardiovascular disease (CVD), or overall mortality...
3.
Hemkens L, Ewald H, Gloy V, Arpagaus A, Olu K, Nidorf M, et al.
Heart
. 2016 Feb;
102(8):590-6.
PMID: 26830663
Colchicine is an old anti-inflammatory drug that has shown substantial cardiovascular benefits in recent trials. We systematically reviewed cardiovascular benefits and harms of colchicine in any population and specifically in...
4.
Hemkens L, Ewald H, Gloy V, Arpagaus A, Olu K, Nidorf M, et al.
Cochrane Database Syst Rev
. 2016 Jan;
(1):CD011047.
PMID: 26816301
Background: Colchicine is an anti-inflammatory drug that is used for a wide range of inflammatory diseases. Cardiovascular disease also has an inflammatory component but the effects of colchicine on cardiovascular...
5.
Nordmann A, Ferreira-Gonzalez I, Kasenda B, Saccilotto R, Bassler D, Bhatnagar N, et al.
Cochrane Database Syst Rev
. 2014 Oct;
(3).
PMID: 25267898
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the clinical benefit and harm of fibrates versus placebo or usual...
6.
Rohner A, Ried K, Sobenin I, Bucher H, Nordmann A
Am J Hypertens
. 2014 Sep;
28(3):414-23.
PMID: 25239480
Background: Many patients prefer herbal medications to conventional drugs. Limited trial evidence suggests that garlic preparations reduce high blood pressure (BP). Methods: We searched electronic databases through March 2014 to...
7.
Vale N, Nordmann A, Schwartz G, de Lemos J, Colivicchi F, Hartog F, et al.
Cochrane Database Syst Rev
. 2014 Sep;
(9):CD006870.
PMID: 25178118
Background: The early period following the onset of acute coronary syndrome (ACS) represents a critical stage of coronary heart disease, with a high risk of recurrent events and deaths. The...
8.
Dell-Kuster S, Lauper S, Koehler J, Zwimpfer J, Altermatt B, Zwimpfer T, et al.
Scand J Work Environ Health
. 2014 Jun;
40(5):493-501.
PMID: 24919161
Objectives: It is unclear to what extent assessments of work ability differ between disability claimants, their treating physicians, and multidisciplinary medical expert teams. Methods: We compared assessments of work ability...
9.
Gloy V, Briel M, Bhatt D, Kashyap S, Schauer P, Mingrone G, et al.
BMJ
. 2013 Oct;
347:f5934.
PMID: 24149519
Objective: To quantify the overall effects of bariatric surgery compared with non-surgical treatment for obesity. Design: Systematic review and meta-analysis based on a random effects model. Data Sources: Searches of...
10.